Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
>=3.0-<10.0%
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
>=3.0-<5.0%
EC/CAS
8052-41-3
Name of the chemical
Stoddard Solvent; Naphtha (petroleum), hydrodesulfurized heavy
Concentration
>=1.0-<3.0%
EC/CAS
91-08-7
Name of the chemical
2,6-Diisocyanattoluol
Concentration
>=0.3-<0.4%
EC/CAS
2530-83-8
Name of the chemical
[3-(2,3-epoxypropoxy)propyl]trimethoxy silane
Concentration
>=0.3-<1.0%
EC/CAS
149-57-5
Name of the chemical
2-ethylhexanoic acid
Concentration
>=0.0-<0.2%
EC/CAS
584-84-9
Name of the chemical
2,4-Diisocyanattoluol
Concentration
>0.03-<0.04%
EC/CAS
1305-78-8
Name of the chemical
Calcium oxide
Concentration
>=0.5-<=1.5%
General Information
Version
4.1
Revision date
2014-12-02
Product name
MasterSeal NP 1 wht also NP1 WHT
Chemical name
sealant
1.2.1 Relevant identified uses
for industrial and professional users * The “Recommended use” identified for this product is provided solely to comply with a US Federal requirement and is not part of the seller"s published specification. The terms of this Safety Data Sheet (SDS) do not create or infer any warranty, express or implied, including by incorporation into or reference in the seller"s sales agreement
Emergency telephone
+1 973 245-6000, 1-800-424-9300
Icons in SDS
Company Information
company name
BASF CORPORATION
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H319, H332, H334, H351, H361, H372
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Signal word
Danger Hazard Statement H332 Harmful if inhaled H319 Causes serious eye irritation H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled H317 May cause an allergic skin reaction H351 Suspected of causing cancer H361 Suspected of damaging the unborn child H372 Causes damage to organs (Central nervous system) through prolonged or repeated exposure Precautionary Statements (Prevention) P280 Wear protective gloves/protective clothing/eye protection/face protection P271 Use only outdoors or in a well-ventilated area P260 Do not breathe dust/gas/mist/vapours P201 Obtain special instructions before use P202 Do not handle until all safety precautions have been read and understood P284 In case of inadequate ventilation] wear respiratory protection P270 Do not eat, drink or smoke when using this product P264 Wash with plenty of water and soap thoroughly after handling P272 Contaminated work clothing should not be allowed out of the workplace Precautionary Statements (Response) P308 + P311 IF exposed or concerned: Call a POISON CENTER or doctor/physician P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P304 + P341 + P311 IF INHALED: If breathing is difficult, remove to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTER or doctor/physician P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing P303 + P352 IF ON SKIN (or hair): Wash with plenty of soap and water P333 + P311 If skin irritation or rash occurs: Call a POISON CENTER or doctor/physician P362 + P364 Take off contaminated clothing and wash before reuse P337 + P311 If eye irritation persists: Call a POISON CENTER or doctor/physician Precautionary Statements (Storage) P405 Store locked up
Precautionary statements
(Disposal) P501 Dispose of contents/container to hazardous or special waste collection point.
2.3 Other hazards
If applicable information is provided in this section on other hazards which do not result in classification but which may contribute to the overall hazards of the substance or mixture. Labeling of special preparations (GHS): SENSITIZATION CAN OCCUR IN SOME INDIVIDUALS, LEADING TO ASTHMA-LIKE SPASMS OF THE BRONCHIAL TUBES AND DIFFICULTY BREATHING. INDIVIDUALS WITH A HISTORY OF RESPIRATORY ILLNESS, ASTHMATIC CONDITIONS, EYE DAMAGE OR TDI SENSITIZATION SHOULD NOT BE EXPOSED TO THIS PRODUCT. TDI IS INCLUDED IN THE NTP ANNUAL REPORT ON CARCINOGENS. RESULTS FROM A TDI HEALTH STUDY INDICATE THAT OVEREXPOSURE TO A RESPIRATORY IRRITANT, RESULTING IN LOWER RESPIRATORY TRACT SYMPTOMS COULD INCREASE THE RISKS OF DEVELOPING ASTHMA-LIKE REACTIONS FROM SUBSEQUENT TDI EXPOSURE. ANIMAL TESTS AND OTHER RESEARCH INDICATE THAT SKIN CONTACT WITH MDI MAY PLAY A ROLE IN CAUSING RESPIRATORY SENSITIZATION. The following percentage of the mixture consists of components(s) with unknown hazards regarding the acute toxicity: 98 - 99 % dermal The following percentage of the mixture consists of components(s) with unknown hazards regarding the acute toxicity: 97 - 99 % oral The following percentage of the mixture consists of components(s) with unknown hazards regarding the acute toxicity: 97 - 100 % Inhalation - dust
2.1 Classification of the substance or mixture
Acute Tox. 4 (Inhalation - vapour) Acute toxicity Eye Dam./Irrit. 2A Serious eye damage/eye irritation Resp. Sens. 1 Respiratory sensitization Skin Sens. 1 Skin sensitization Carc. 2 Carcinogenicity Repr. 2 (unborn child) Reproductive toxicity STOT RE 1 Specific target organ toxicity — repeated exposure